Related Experiment Video
Updated: Feb 11, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal
Siming Yu1, Linna Li2, Wei Tian1
1Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), Harbin Medical University, Harbin, Heilongjiang, China.
Background And Purpose:
PEP06, a polypeptide modified from endostatin, was investigated for its antitumour effects on colorectal cancer (CRC) and the possible mechanisms of this antitumour activity were examined in in vitro and in vivo models.
Experimental Approach:
After PEP06 treatment, cell proliferation and migration assays were performed in CRC cells. Epithelial-mesenchymal transition (EMT) progression was determined by Western blotting, immunofluorescent staining and immunohistochemistry in vitro and in a residual xenograft model. MiRNAs regulated by PEP06 were identified by miRNA microarray and verified by in situ hybridization and quantitative real-time PCR. The interactions between PEP06 and integrin αvβ3 were determined with Biacore SA biochips. The cellular function of miR-146b-5p was validated by gain-of-function and loss-of-function approaches. A mouse model of lung metastasis was used to determine the effect of PEP06 on metastatic growth.
Key Results:
PEP06 did not affect cell viability but reduced migration and EMT in SW620 and HCT116 cells. PEP06 significantly repressed the expression of miR-146b-5p in these two cell lines through binding to integrin αvβ3. MiR-146b-5p was shown to increase EMT by targeting Smad4, and the miR-146b-5p-Smad4 cascade regulated EMT in CRC. PEP06 also suppressed CRC pulmonary metastasis, increased survival of mice and hampered residual tumour growth by inhibiting EMT through down-regulating miR-146b-5p.
Conclusions And Implications:
PEP06 is a polypeptide that inhibits the growth and metastasis of colon cancer through its RGD motif binding to integrin αvβ3, thereby down-regulating miR-146b-5p to inhibit EMT in vitro and in vivo. It might have potential as a therapeutic for CRC.
Insights
PEP06, a modified endostatin polypeptide, inhibits colorectal cancer (CRC) cell migration and metastasis. It targets integrin αvβ3 to down-regulate miR-146b-5p, thereby suppressing epithelial-mesenchymal transition (EMT) and improving survival.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Colorectal cancer (CRC) remains a significant health challenge.
- Investigating novel therapeutic strategies is crucial for improving patient outcomes.
- Endostatin derivatives show promise in preclinical cancer models.
Purpose of the Study:
- To evaluate the antitumour effects of PEP06, a modified endostatin polypeptide, on colorectal cancer (CRC).
- To elucidate the underlying mechanisms of PEP06's antitumour activity in vitro and in vivo.
- To explore PEP06's potential as a therapeutic agent for CRC.
Main Methods:
- Cell proliferation, migration, and epithelial-mesenchymal transition (EMT) assays were conducted in CRC cell lines.
- Western blotting, immunofluorescence, and immunohistochemistry were used to assess EMT markers.
- MiRNA expression profiling, in situ hybridization, and quantitative real-time PCR identified regulated miRNAs.
- Biacore SA biochips analyzed PEP06-integrin αvβ3 interactions.
- Gain- and loss-of-function studies validated miR-146b-5p's role.
- A mouse model assessed PEP06's effect on lung metastasis.
Main Results:
- PEP06 reduced CRC cell migration and EMT without affecting cell viability.
- PEP06 suppressed miR-146b-5p expression by binding to integrin αvβ3.
- The miR-146b-5p-Smad4 pathway was identified as a regulator of EMT in CRC.
- PEP06 inhibited pulmonary metastasis, enhanced mouse survival, and reduced residual tumor growth.
Conclusions:
- PEP06 inhibits CRC growth and metastasis by binding to integrin αvβ3, down-regulating miR-146b-5p, and suppressing EMT.
- The RGD motif in PEP06 is critical for its interaction with integrin αvβ3.
- PEP06 demonstrates potential as a novel therapeutic agent for colorectal cancer.
Related Concept Videos
Phase Transitions
Phase Transitions: Sublimation and Deposition
Feedback Inhibition
Properties of Transition Metals
Cooperative Allosteric Transitions
Phase Transitions: Vaporization and Condensation

